Cloud Alpha Capital Management Limited Editas Medicine, Inc. Transaction History

Cloud Alpha Capital Management Limited

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$39.27 - $72.94 $8.68 Million - $16.1 Million	-221,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$31.29 - $56.64 $1.41 Million - $2.55 Million	45,000 Added 25.57%	221,000 $12.5 Million
Q1 2021 May 14, 2021	BUY	$39.71 - $90.58 $6.95 Million - $15.9 Million	175,000 Added 17500.0%	176,000 $7.39 Million
Q4 2020 Mar 19, 2021	BUY	$27.07 - $84.35 $27,070 - $84,350	1,000 New	1,000 $70,000

244

69.3M

564K

428K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $316M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Cloud Alpha Capital Management Limited, based on Form 13F filings with the SEC.

Stay updated on Cloud Alpha Capital Management Limited with notifications on news.